Skip to main content

Accelerate discovery and clinical translation

We have a responsibility to conduct high impact research that ultimately makes a difference in people’s lives. We need to increase the depth, breadth and quality of our research. This will attract more talent and research funding and help us move faster in reaching our ultimate goal, which is preventing disease, alleviating suffering and saving lives.

yellow circle with outline of microscope, beaker and books

Goals

  • Increase the impact of scientific discovery and clinical translation.
  • Increase NIH funding to be in the top 10 public medical schools by 2030.
  • Diversify sources of research funding, including increasing focus on industry partnerships. 
  • Increase the number of patients enrolled in clinical trials to ensure clinical research adequately reflects the people of Indiana.
  • Increase the national recognition of our faculty and staff.

Objectives

  • Build interdisciplinary team-based programs in areas where IU School of Medicine can be a national leader (within institutes and in other priority areas).
  • Balance recruitments to support bench to bedside programs.
  • Recruit more researchers in population health, community health and health care access.
  • Address basic science and clinical research infrastructure needs, particularly in areas of critical staffing shortages.
  • Enhance support for developing programmatic funding proposals.
  • Increase the number of MD/PhD students and create programs to better support physician-scientist career development.
  • Formalize mentoring program for midcareer faculty.

Metrics

 

Raise total research funding to $600 million by 2030.

The school was awarded $548 million in research funding in 2025.

The total dollar amount of research awards received per calendar year. Multi-year awards are prorated over duration of the project.

Data displayed is for the 2025 calendar year.

Updated June 29, 2026

 

 

Increase NIH research funding to $378 million by 2030.

The school was awarded $233 million in research funding from the NIH in 2025.

The total dollar amount of National Institute of Health awards received per calendar year. Multi-year awards are prorated over duration of the project.

Data displayed is for the 2025 calendar year.

Updated June 29, 2026

 

 

Advance the school's Blue Ridge ranking for public medical schools to top 10.

IU School of Medicine was ranked 15th in the Blue Ridge rankings for public medical schools in 2025.

 

IU School of Medicine's ranking among public medical schools on the annual report from Blue Ridge Institute for Medical Research.

Data displayed is for the 2025 federal fiscal year.

Updated June 29, 2026

Share your feedback

We encourage bidirectional communication with our faculty, staff, learners, alumni and broader community. Please share your ideas on how to make the School of Medicine and our work better.

Recent Stories

Dr. Frank Yuk performs a spinal operation in the OR

New spine neurosurgeon brings passion for minimally invasive care to IU

With formal training in both neurosurgery and orthopedic spine surgery, Frank Yuk provides comprehensive care for the full spectrum of spinal disorders through a multidisciplinary approach.

August 05, 2026

Kyle Gospodarek stands in a lab at the IU Hydrocephalus Research Center. He is wearing a blue shirt and tie and has a short buzzcut.

Living with hydrocephalus: IU professor shares his story as Hydrocephalus Research Center aims to develop non-surgical treatments

Kyle Gospodarek has lived with hydrocephalus since age 6. Now an assistant professor at IU School of Medicine—Northwest-Gary, he will be speaking at the 2026 HA Connect National Conference on Hydrocephalus on what it's like growing up with this debilitating medical condition.

July 21, 2026

A group photo of the 2026 CTMC cohort

National training program prepares early-career investigators to lead neurological clinical trials

Funded by the National Institute for Neurological Disorders and Stroke, the Clinical Trials Methodology Course is designed to train investigators with limited clinical research experience in the best practices of clinical trial design and execution.

July 20, 2026